US Patent Issued to JIANGSU ALPHAMAB BIOPHARMACEUTICALS on March 3 for "Bispecific fusion protein for tumor treatment" (Chinese Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,531, issued on March 3, was assigned to JIANGSU ALPHAMAB BIOPHARMACEUTICALS Co. LTD. (Suzhou, China).

"Bispecific fusion protein for tumor treatment" was invented by Ting Xu (Suzhou, China), Kangping Guo (Suzhou, China), Junfang Xu (Suzhou, China), Pilin Wang (Suzhou, China) and Yuhao Jin (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a use of a dimer in the preparation of a medicament for treating a tumor in a subject in need thereof, and the dimer formed by two polypeptide chains, with each of the two polypeptide chains comprising an antibody Fc subunit, wherein the dimer comprises two or more immunog...